Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
about
Immune-mediated vascular injury and dysfunction in transplant arteriosclerosisMouse models of arteriosclerosis: from arterial injuries to vascular grafts.Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathyCoinhibitory T-cell signaling in islet allograft rejection and tolerance.Induction of immunologic tolerance for transplantation.Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.Endothelin-1 receptor blockade and its effect on chronic rejection.Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.CD40/154 blockade and rejection of islet allografts in the streptozotocin and autoimmune diabetic rat.Costimulatory blockade by the induction of an endogenous xenospecific antibody response
P2860
Q28084366-72FC3EB1-B47E-43C5-9FDE-19A29B3420A9Q30481132-DC7B7A8B-52F5-4EA6-B61D-76FAAA4C6018Q34769796-282ECC10-BEEC-4881-9124-C943158BF9B1Q34925487-7E919563-1664-41B8-8690-ABB881BF33EBQ36335977-D6AD271B-4494-4FF3-A647-765CC94917D2Q36485931-DE7134BB-ED45-4BCF-A8E2-13146C205D37Q40827011-24799494-D1CD-4EBF-A40E-5A358DA77458Q41830915-6F2AF31C-0AF9-44D7-8576-8F3DD6127277Q42382043-9A191730-42B4-438D-80D8-2B2BBA3B1A25Q42407348-D2BE1BB2-0382-4776-BA41-EB2E6888852EQ43988928-3F29F499-053C-432D-A411-B4771325CF98Q44796618-62236511-B2BD-4EC9-AD48-2FF5BA26F769Q58836916-CC3AE14E-4D48-44B7-BBB9-5F1B5C8D0B25
P2860
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@ast
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@en
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@nl
type
label
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@ast
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@en
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@nl
prefLabel
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@ast
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@en
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@nl
P2093
P2860
P1433
P1476
Prevention of chronic rejectio ...... 40 ligand monoclonal antibody.
@en
P2093
A Aitouche
L A Valdivia
M H Sayegh
P S Linsley
V Subbotin
P2860
P304
P356
10.1097/00007890-199712270-00035
P577
1997-12-01T00:00:00Z